Status
Conditions
Treatments
About
This study aims to assess the reliability of the Elbow Performance Test as an upper extremity-based alternative for evaluating sarcopenia severity. Unlike traditional lower extremity-focused assessments, this test may offer a practical solution for individuals with mobility limitations or comorbidities affecting the lower limbs. Participants will include older adults with sarcopenia and healthy young adults. Functional tests, including the 4-meter Gait Speed Test, SPPB, TUG, and the Elbow Performance Test, will be administered twice within a 7-10-day interval. Reliability will be analyzed using intraclass correlation coefficients (ICC).
Full description
Background:Sarcopenia is a generalized and progressive skeletal muscle disorder characterized by a decline in muscle strength, mass, and function. The severity of sarcopenia is commonly assessed using functional performance tests, which are also used for monitoring disease progression and treatment response. However, lower extremity-based tests may have limited applicability in the presence of various comorbidities.
Objective: This study proposes an upper extremity-based alternative, the Elbow Performance Test, and aims to evaluate its reliability in comparison to the commonly used 4-meter Gait Speed Test.
Method:This planned cross-sectional study will include two groups: older adults with sarcopenia and healthy young adults. All participants will undergo the 4-meter Gait Speed Test, the Short Physical Performance Battery (SPPB), the Timed Up and Go (TUG) test, and the Elbow Performance Test on two separate occasions, with a 7-10-day interval between sessions. In the Elbow Performance Test, a 1-kilogram sandbag will be attached to the distal forearm of the dominant arm, and participants will be instructed to perform 30 consecutive elbow flexion-extension movements. The total time required to complete the repetitions will be recorded. The reliability of the test will be evaluated using intraclass correlation coefficients (ICC).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Individuals who consent to participate in the study
*Sarcopenia Group
Male participants aged 60 years or older
Diagnosed with sarcopenia according to EWGSOP2 criteria
*Healthy Young Control Group
Male participants aged 40 years or younger
SARC-F screening test score < 4
Exclusion criteria
96 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal